Press Release

Bridge to Life Sells Certain Assets to TransMedics

August 3, 2023

San Diego – August 3, 2023 – Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics. Lawyers Rowook Park, Jenny Ge, Alison Freeman-Gleason and Melissa Meza led the Cooley team, with valuable support from Rishab Kumar, and Lauren Creel is advising and supporting Bridge to Life on general corporate matters, including in connection with the sale.

Bridge to Life will use the proceeds from the divestiture to focus on its core preservation solutions business and its pending Food and Drug Administration submission for the VitaSmart Liver Machine Perfusion System.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.